Send the following on WhatsApp
Continue to Chat百濟神州宣佈百悅澤(R)(澤布替尼)獲歐洲藥品管理局受理治療慢性淋巴細胞白血病和邊緣區淋巴瘤的上市許可申請 https://geneonline.news/leukemia-lymphoma/?variant=zh-cn
百濟神州宣佈百悅澤(R)(澤布替尼)獲歐洲藥品管理局受理治療慢性淋巴細胞白血病和邊緣區淋巴瘤的上市許可申請 https://geneonline.news/leukemia-lymphoma/?variant=zh-cn